4//SEC Filing
Dube Eric M 4
Accession 0001415889-25-002006
CIK 0001438533other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 8:39 PM ET
Size
5.2 KB
Accession
0001415889-25-002006
Insider Transaction Report
Form 4
Dube Eric M
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Sale
Common Stock
2025-01-22$19.46/sh−10,736$208,923→ 351,239 total
Footnotes (1)
- [F1]This sale was made pursuant to a written plan adopted on March 15, 2024, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001763494
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 8:39 PM ET
- Size
- 5.2 KB